Fig. 4From: Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammationOrexin A strikingly diminishes demyelinating processes, astrogliosis, and microglial/macrophage responses in the CNS. On day 21 post-immunization, spinal cord sections from naĆÆve, PBS, and OxA groups were prepared and labeled with a Alexa 488 anti-MBP or Alexa 488 anti-GFAP, and b DAPI, Cy3 anti-Iba-1, and Alexa 488 anti-Arg-1 stainings. All images were taken at Ćā20 magnification. Two representative areas of spinal cord are shown per experimental group. Graphs show the percentage of MBP, GFAP, and Iba1 immunoreactive areas as well as the Arg-1-positive cell number per mm2 of each group (nā=ā7/group). *Pā<ā0.05 (Mann-Whitney test, compared to PBS group). ND not detectableBack to article page